Infection prevention and control programs in Armenian Psychoneurological Hospitals
- 作者: Palozyan G.O.1, Avetisyan S.M.1, Abovyan R.A.1, Melik-Andreasyan G.G.1
-
隶属关系:
- National Center of Disease Control and Prevention of the Ministry of Health of Armenia
- 期: 卷 14, 编号 1 (2024)
- 页面: 163-169
- 栏目: ORIGINAL ARTICLES
- URL: https://journal-vniispk.ru/2220-7619/article/view/256777
- DOI: https://doi.org/10.15789/2220-7619-IPA-17610
- ID: 256777
如何引用文章
全文:
详细
Aim of the study: to characterize the integration and implementation of the main components of infection prevention and control (IPC), defined by the World Health Organization (WHO), in psychoneurological hospitals in Armenia.
Materials and methods. The study was conducted over the period from 2019 to 2022 in all 8 psychoneurological hospitals in Armenia. The research tool was based on using the IPCAF (Infection Prevention and Control Assessment Framework) questionnaire translated into Armenian, consisting of 8 sections. In accordance with the WHO scoring methodology, each possible answer to the question was scored. The maximum total score for each core component could be 100 points, and the final score — 800. Descriptive epidemiology was used during the study.
Results. The average final score for all IPCAF components for all neuropsychiatric hospitals in Armenia over the entire study period was increased by 1.46 times (from 345.0±10.7 points in 2019 to 502.5±32.5 in 2022; р < 0.01) and in 2022 was characterized as an “intermediate level”. Analysis by individual IPC core components (CC) found that the highest average scores in 2022 were obtained for components CC2 (IPC guidelines) — 81.6 points, CC8 (Built environment, materials and equipment for IPC at the facility level) — 72.8 points, and CC5 (Multimodal strategies) — 70.0 points. The lowest average scores were obtained for the key components: CC4 (Health care-associated infection (HAI) surveillance) — 45.0 points, and for CC3 (IPC education and training) — 56.3 points and CC7 (Workload, staffing and bed occupancy) — 56.9 points.
Conclusion. Our study demonstrated for the first time an opportunity for using the IPCAF questionnaire to evaluate IPC programs in neuropsychiatric hospitals and identify gaps in various areas of IPC. Information was received regarding the state of key IPC component implementation in psychoneurological hospitals in Armenia. Analysis by individual core components identified gaps that need to be addressed. It is recommended to implement continuous monitoring of compliance with various aspects of IPC in order to prevent weakening of control and deterioration of epidemiological situation.
作者简介
G. Palozyan
National Center of Disease Control and Prevention of the Ministry of Health of Armenia
编辑信件的主要联系方式.
Email: ncdc.palozyan@gmail.com
Epidemiologist, Department of Epidemiology of Communicable and Non-Communicable Diseases
亚美尼亚, ErevanSh. Avetisyan
National Center of Disease Control and Prevention of the Ministry of Health of Armenia
Email: ncdc.palozyan@gmail.com
Epidemiologist, Department of Epidemiology of Communicable and Non-Communicable Diseases
亚美尼亚, ErevanR. Abovyan
National Center of Disease Control and Prevention of the Ministry of Health of Armenia
Email: ncdc.palozyan@gmail.com
Head of the Department of Epidemiology of Communicable and Non-Communicable Diseases
亚美尼亚, ErevanG. Melik-Andreasyan
National Center of Disease Control and Prevention of the Ministry of Health of Armenia
Email: ncdc.palozyan@gmail.com
DSc (Medicine), Professor, Deputy-Director for Scientific Work
亚美尼亚, Erevan参考
- Палозян Г.О. Оценка программ профилактики инфекций и инфекционного контроля в стационарах Армении в 2019 году с помощью международного инструмента IPCAF // Медицинская наука Армении. 2022. № 4. С. 86–93. [Palozyan G. Evaluation of IPC programs in Armenian hospitals in 2019 with IPCAF tool. Meditsinskaya nauka Armenii = Medical Science of Armenia, 2022, no. 4, pp. 86–93.] doi: 10.54503/0514-7484-2022-62.4-86
- Палозян Г.О., Аветисян Ш.М., Абовян Р.А., Мелик-Андреасян Г.Г., Ванян А.В. Оценка внедрения программ профилактики и инфекционного контроля в стационарах Армении на фоне пандемии COVID-19 // Инфекция и иммунитет. 2022. Т. 12, № 6. C. 1149–1155. [Palozyan G.H., Avetisyan Sh.M., Abovyan R.A., Melik-Andreasyan G.G., Vanyan A.V. Assessing implementation of prevention and infection control programs in armenian hospitals during the COVID-19 pandemic. Infektsiya i immunitet = Russian Journal of Infection and Immunity, 2022, vol. 12, no. 6, pp. 1149–1155. (In Russ.)] doi: 10.15789/2220-7619-AIO-2044
- Палозян Г.О., Аветисян Ш.М., Абовян Р.А., Мелик-Андреасян Г.Г., Ванян А.В. Оценка программ профилактики инфекций и инфекционного контроля в стационарах Армении в 2019–2021 гг. // Материалы V съезда эпидемиологов, медицинских микробиологов и паразитологов Армении (с международным участием). Ереван, 2022. C. 90–94. [Palozyan G., Avetisyan Sh., Abovyan R. Melik-Andreasyan G., Vanyan A. Evaluation of IPC programs in Armenian hospitals in 2019–2021. Materials of 5th Congress of epidemiologists, medical microbiologists and parasitologists of Armenia (with international participation). Yerevan, 2022, pp. 90–94.]
- Allegranzi B., Bagheri Nejad S., Combescure C., Graafmans W., Attar H., Donaldson L., Pittet D. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet, 2011, vol. 377, no. 9761, pp. 228–241. doi: 10.1016/S0140-6736(10)61458-4
- Alp E., Damani N. Healthcare-associated infections in intensive care units: epidemiology and infection control in low-to-middle income countries. J. Infect. Dev. Ctries, 2015, vol. 9, no. 10, pp. 1040–1045. doi: 10.3855/jidc.6832
- Cosgrove S.E. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin. Infect. Dis., 2006, vol. 42, suppl. 2, pp. S82-S89. doi: 10.1086/499406
- Dickstein Y., Nir-Paz R., Pulcini C., Cookson B., Beović B., Tacconelli E., Nathwani D., Vatcheva-Dobrevska R., Rodríguez-Baño J., Hell M., Saenz H., Leibovici L., Paul M. Staffing for infectious diseases, clinical microbiology and infection control in hospitals in 2015: results of an ESCMID member survey. Clin. Microbiol. Infect., 2016, vol. 22, no. 9, pp. 812.e9-812.e17. doi: 10.1016/j.cmi.2016.06.014
- Hansen S., Schwab F., Gropmann A., Behnke M., Gastmeier P.; PROHIBIT Consortium. [Infection control and safety culture in German hospitals (In German)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2016, vol. 59, no. 7, pp. 908–915. doi: 10.1007/s00103-016-2373-0
- Hansen S., Zingg W., Ahmad R., Kyratsis Y., Behnke M., Schwab F., Pittet D., Gastmeier P.; PROHIBIT study group. Organization of infection control in European hospitals. J. Hosp. Infect., 2015, vol. 91, no. 4, pp. 338–345. doi: 10.1016/j.jhin.2015.07.011
- Laxminarayan R., Duse A., Wattal C., Zaidi A.K., Wertheim H.F., Sumpradit N., Vlieghe E., Hara G.L., Gould I.M., Goossens H., Greko C., So A.D., Bigdeli M., Tomson G., Woodhouse W., Ombaka E., Peralta A.Q., Qamar F.N., Mir F., Kariuki S., Bhutta Z.A., Coates A., Bergstrom R., Wright G.D., Brown E.D., Cars O. Antibiotic resistance-the need for global solutions. Lancet Infect. Dis., 2013, vol. 13, no. 12, pp. 1057–1098. doi: 10.1016/S1473-3099(13)70318-9
- Mehrad B., Clark N.M., Zhanel G.G., Lynch J.P. 3rd. Antimicrobial resistance in hospital-acquired gram-negative bacterial infections. Chest, 2015, vol. 147, no. 5, pp. 1413–1421. doi: 10.1378/chest.14-2171
- Report on the endemic burden of healthcare-associated infection worldwide. Geneva: World Health Organization, 2011. URL: http://apps.who.int/iris/bitstre am/10665/80135/1/9789241501507_eng.pdf (18.08.2021)
- Shekelle P.G., Pronovost P.J., Wachter R.M., McDonald K.M., Schoelles K., Dy S.M., Shojania K., Reston J.T., Adams A.S., Angood P.B., Bates D.W., Bickman L., Carayon P., Donaldson L., Duan N., Farley D.O., Greenhalgh T., Haughom J.L., Lake E., Lilford R., Lohr K.N., Meyer G.S., Miller M.R., Neuhauser D.V., Ryan G., Saint S., Shortell S.M., Stevens D.P., Walshe K. The top patient safety strategies that can be encouraged for adoption now. Ann. Intern. Med., 2013, vol. 158, no. 5, pt 2, pp. 365–368. doi: 10.7326/0003-4819-158-5-201303051-00001
- Struelens M.J., Wagner D., Bruce J., MacKenzie F.M., Cookson B.D., Voss A., van den Broek P.J., Gould I.M.; ARPAC Steering Group. Status of infection control policies and organisation in European hospitals, 2001: the ARPAC study. Clin. Microbiol. Infect., 2006, vol. 12, no. 8, pp. 729–737. doi: 10.1111/j.1469-0691.2006.01462.x
- WHO. Guidelines on Core components of Infection Prevention and control Programmes at the national and acute health care facility level. World Health Organization. 2016. URL: https://apps.who.int/iris/bitstream/handle/10665/251730/9789241549929-eng.pdf?sequence=1 (27.02.2019)
- WHO. Infection Prevention and Control Assessment Framework. World Health Organization. 2018. URL: https://www.who.int/infection-prevention/tools/core-components/IPCAF-facility.pdf (27.02.2019)
- WHO. Minimum requirements for infection prevention and control programmes. 2019. URL: https://www.who.int/publications/i/item/9789241516945
补充文件
